Education
About Us
Working with TipRanks
Follow Us
ExpreS2ion Biotech Holding AB (SE:EXPRS2)
:EXPRS2
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
EXPRS2 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
kr23.5
Hold
-3.69%
Downside
Reiterated
07/19/25
ExpreS2ion Biotech Holding AB's overall stock score is primarily affected by its poor financial performance, characterized by consistent net losses and negative cash flow. Technical analysis provides some neutral to slightly positive signals, but valuation remains weak with a negative P/E ratio. The lack of earnings call data and corporate events means these components did not influence the score.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
kr23.5
Hold
-3.69%
Downside
Reiterated
07/19/25
ExpreS2ion Biotech Holding AB's overall stock score is primarily affected by its poor financial performance, characterized by consistent net losses and negative cash flow. Technical analysis provides some neutral to slightly positive signals, but valuation remains weak with a negative P/E ratio. The lack of earnings call data and corporate events means these components did not influence the score.
EXPRS2 Analyst Recommendation Trends
Rating
May 25
Jun 25
Strong Buy
0
0
Buy
0
0
Hold
2
4
Sell
0
0
Strong Sell
0
0
total
2
4
Each month's total comprises the sum of three months' worth of ratings.
EXPRS2 Stock Forecast FAQ
What is SE:EXPRS2’s average 12-month price target, according to analysts?
Based on analyst ratings, ExpreS2ion Biotech Holding AB’s 12-month average price target is 22.47.
What is SE:EXPRS2’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:EXPRS2, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ExpreS2ion Biotech Holding AB a Buy, Sell or Hold?
ExpreS2ion Biotech Holding AB has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is ExpreS2ion Biotech Holding AB’s share price target?
The average share price target for ExpreS2ion Biotech Holding AB is 22.47. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr22.47 ,and the lowest forecast is kr22.47. The average share price target represents -7.93% Decrease from the current price of kr24.4.
The highest analyst share price target is kr22.47 ,and the lowest forecast is kr22.47. The average share price target represents -7.93% Decrease from the current price of kr24.4.
What do analysts say about ExpreS2ion Biotech Holding AB?
ExpreS2ion Biotech Holding AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of ExpreS2ion Biotech Holding AB?
To buy shares of SE:EXPRS2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.